Nawab Qizilbash

Clinical Epidemiologist & Head of OXON - OXON Epidemiology

Nawab Qizilbash, MBChB MRCP(UK) BSc MSc DPhil (Oxon), is Senior Clinical Epidemiologist at OXON Epidemiology and:

•    Honorary Associate Professor in Epidemiology, London School of Hygiene and Tropical Medicine.

•    Clinical Observer in Internal Medicine, Madrid

•    Member of Green Templeton College, Oxford University.

•    Co-author of x7 Lancet, x1 JAMA and x3 BMJ publications in epidemiology, pragmatic trials and meta-analysis.

•    Chief Editor of 'Evidence-based Dementia Practice' published by Blackwell's, Oxford.

Activities at the European Medicines Agency supported ENCePP: Author on Methods Guide: Chapter on Systematic reviews and meta-analyses of safety studies and section on Primary data Collection Studies and formerly Steering Group member.

Nawab was Director, Clinical Epidemiology, GSK (1997-2005). He trained under and worked with Professor Sir Richard Peto F.R.S. (inventor of: Log-rank test, Peto method for meta-analysis, Regression dilution bias adjustment, pioneer of large pragmatic trials and Peto´s Paradox) in epidemiology, trials and meta-analysis, and was founding editor of the Cochrane Dementia Group. Nawab also trained in general internal medicine and geriatrics under Professor Sir John Grimley Evans and was Honorary Consultant Physician at the Radcliffe Infirmary, Oxford (1997-2000).
 

OXON Epidemiology is a leading European-based full service scientific and operational provider.

We conduct global multi-country field and secondary data real-world studies, pragmatic trials  and data synthesis for Safety, Market Access & Clinical Development in all major therapy areas, orphan conditions and pregnancy.

We have strong links with London School of Hygiene & Tropical Medicine, regulators, ENCePP, and our staff have co-authored x11 Lancets and x2 NEJM.